Does multiparametric MRI increase Oncologic outcomes in prostate cancer?
Loading...
Identifiers
Publication date
Authors
Advisors
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
The purpose of this study is to compare the 4-year biochemical
disease-free survival (BDFS) of patients with prostate cancer
(PCa) staged according to multiparametric MRI (mpMRI) and
treated with radical prostatectomy (RP) versus intensity-modulated
radiation therapy (IMRT) ≥76 Gy ± hormonal therapy (HT).
Description
UNESCO Subjects
Keywords
Bibliographic reference
Couñago, F., del Cerro, E., Díaz Gavela, A., Rodríguez Luna, J. M., Marcos, F. J., Pérez-Coca, J., Thuissard, I. J., Olaciregui, K., Mateo, M., & Sanz-Rosa, D. (2015). Does multiparametric MRI increase Oncologic outcomes in prostate cancer? In: XVIII Congreso de la SEOR. Clinical & Translational Oncology, 17(extra. 1), 103.







